Other events in Perth

Science in the community

Wheelchair Accessible Venue
Auslan Interpreted Event(s)
Past event - 2019
20 May Doors open 6 pm | Start time 6.30 pm | End time 8.30 pm
The Brisbane, 292 Beaufort St, Highgate,
Perth 6003
Presenters will cover a variety of topics from community involvement in research to genome engineering.

Auslan Interpreted Event

Consumer and community involvement in research

Miss Briony Williams (Consumer Advocate, Consumer and Community Health Research Network)
How can consumers and members of the community get involved in research? Come along to hear how you could take part in research that could have important implications for policy decisions.

Briony Williams is a Consumer Advocate with the Consumer & Community Health Research Network. Her role is to support researchers to work in partnership with consumer and community members to make decisions about health research priorities, policy and practice.

Is human genome engineering inevitable?

Dr Archa Fox (Associate Professor, ARC Future Fellow, University of Western Australia)
With the new CRISPR Cas9 technology we can now easily 'edit' DNA, opening the possibility of human genome engineering, amongst other applications. So what’s all the fuss about and how should we feel about the first ever human CRISPR babies?

Dr Fox studied at the Uni of Sydney and NSW, and has worked at the Uni of Dundee, UK, and the Uni of WA. She is an ARC Future Fellow, and in 2017 was awarded the Emerging Leader Award by the Australian/NZ Society of Cell and Developmental Biology.

Importance of Vaccines

Dr Shakeel Mowlaboccus (Research Scientist, University of Western Australia)
Prevention is better than cure. Preventing the spread of infectious diseases is empirical for protecting yourself and your community. Here, I will discuss the importance of vaccines and address some of the misconceptions attributed to their use.

Dr Mowlaboccus is a molecular biologist who works on the epidemiology of meningococcal disease in WA. His publications addressed the coverage of the new serogroup B vaccine in Australia and his current focus is on antimicrobial resistance.